Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

spantide III

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Recently, we identified an orphan Bombyx mori neuropeptide G protein-coupled receptor (BNGR)-A24 as an ion transport peptide-like… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2014
Highly Cited
2014
Neuropeptide substance P (SP) has been implicated in inflammation, pain, depression and breast cancer cell (BCC) growth. Here, we… Expand
Highly Cited
2007
Highly Cited
2007
BackgroundAcute cutaneous neurogenic inflammation initiated by activation of transient receptor potential vanilloid-1 (TRPV1… Expand
  • figure 7
2006
2006
Background  There is increasing evidence that neuropeptides, especially substance P (SP), may be involved in the pathogenesis of… Expand
1999
1999
Because substance p (SP) has been reported to be released from cutaneous sensory nerve endings after hapten application, we… Expand
1998
1998
We have investigated the effects of the substance P C-terminal octapeptide analogues [Pro4, Glu (OBzl)11] SP4-11, [Hyp4, Glu(OBzl… Expand
1997
1997
Electroconvulsive treatment (ECT) of rabbits produced ocular inflammation consisting of conjunctival hyperaemia, miosis and… Expand
1993
1993
Electrical spike activity of ganglion cells has been recorded extracellularly in the teleost (roach) retina, and effects of a… Expand
1991
1991
We compared the ability of spantide I and II to antagonize tachykinins in monoreceptor bioassays. Both peptides antagonized the… Expand
1990
1990
The effects of unilateral injections of two substance P fragments, the N-terminal substance P (1-7) (SP1-7) and the C-terminal… Expand